Edesa Biotech, Inc.
(NASDAQ : EDSA)

( )
EDSA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.63%35.090.9%$1197.25m
JNJJohnson & Johnson
-0.21%131.250.7%$859.25m
MRKMerck & Co., Inc.
-0.18%86.750.6%$783.59m
ABBVAbbVie, Inc.
-0.04%67.512.3%$640.39m
BMYBristol-Myers Squibb Company
0.15%47.841.4%$636.07m
LLYEli Lilly and Company
0.10%111.571.0%$423.54m
AZNAstraZeneca PLC Sponsored ADR
0.02%45.431.2%$175.47m
NVSNovartis AG Sponsored ADR
-1.24%89.000.2%$174.32m
GSKGlaxoSmithKline plc Sponsored ADR
0.71%40.980.3%$96.41m
NVONovo Nordisk A/S Sponsored ADR Class B
1.70%52.700.1%$74.69m
SNYSanofi Sponsored ADR
-1.46%42.570.2%$48.72m
LCILannett Company, Inc.
-2.56%6.8436.6%$4.66m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.81%1.781.6%$3.40m
EPIXESSA Pharma Inc
-5.26%1.800.1%$0.04m

Company Profile

Edesa Biotech, Inc. is a biopharmaceutical company. It focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company was founded in 2015 and is headquartered in Port Hueneme, CA.